5WPR Releases the Hospitality Celebrity Index

Apotex Announces FDA Approval of Generic Infuvite® Pediatric Injection, Eligible for 180‑day CGT Exclusivity (Single‑Dose Vial), Complementing its Recent Approval of Generic Infuvite Adult Injection

New Verato Report: 85% of Surveyed Consumers Consider Switching Providers Over Identity Errors

Sage Growth Partners Promotes Amrita Mehta and Ben Kovalick to Senior Strategy Consultants

A&G Wins Top Firmwide Honor in 20th Annual M&A Advisor Turnaround Awards

BioMarin Completes Acquisition of Amicus Therapeutics

Medical Clinic of Houston Internist and Geriatrician Holly Holmes, MD, MS, AGSF Offers Patients the Concierge Choice Program from Concierge Choice Physicians

AbbVie Submits Regulatory Application to FDA for SKYRIZI® (risankizumab-rzaa) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease

CSI Pharmacy Becomes First Multi-Location Specialty Pharmacy to Achieve ACHC Distinction in Ig Therapy in Partnership with IgNS

FDA grants Priority Review for IMAAVY® (nipocalimab-aahu) as the potential first approved treatment for people living with warm autoimmune hemolytic anemia (wAIHA)

TransCode Therapeutics Appoints Dr. Anna Moore as Chair of Scientific Advisory Board; Announces Sponsored Research Agreement with Michigan State University

Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib (IBTROZI®) as Recommended Option to Clinical Practice Guidelines in Oncology for Central Nervous System Cancers

Xcovery Partners with EVERSANA to Commercialize Lung Cancer Drug Ensacove in the U.S.

Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA

Conscientia Health Launches Virtual Primary Care Services - A Groundbreaking Breakthrough in AI-Powered Integrative Telehealth Uniting Mental and Physical Health For Whole Person Care Under One Virtual Roof.

BioMarin to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, May 4, 2026, at 4:30pm ET

ADC Therapeutics to Host First Quarter 2026 Financial Results Conference Call on May 4, 2026

The EXCEL - First-of-its-kind study highlights critical role of essential phospholipids in improving Fatty Liver Disease

One Capsule, Endless Glow--Radiant Skin Starts Within

Galaxy Therapeutics Submits Final Module of PMA to U.S. FDA for SEAL™ Device in Wide-Neck Bifurcation Aneurysms

Armata Pharmaceuticals Announces Appointment of Biopharmaceutical Commercial Executive Daniel B. Gilmer, Ph.D. to its Board of Directors

Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera

CONCEPT MEDICAL ANNOUNCES PRELIMINARY 3-YEAR SIRONA DATA AT CHARING CROSS SYMPOSIUM 2026

Cellenkos, Inc. Announces FDA Clearance to Initiate Phase 2 Clinical Trial of CK0801 (Allogeneic Cord Blood-Derived Tregs) for Aplastic Anemia

Hourglass International Introduces Nusa200™: A USA-Made Nitrile Exam Glove Engineered for Efficiency, Comfort, and Reliable Protection

Shareholder Alert: Ademi LLP investigates whether Organon & Co. is obtaining a Fair Price for Public Shareholders

SMOAKLAND'S 1776 COMPASSION PROJECT: A YEAR'S SUPPLY OF MEDICAL CANNABIS FREE TO MILITARY VETERANS FOR 2026!

Pulmonary Arterial Hypertension Market Outlook Shows Strong Upward Trend at a CAGR of 6.7% During the Study Period (2022-2036) Supported by New Clinical Developments | DelveInsight

Redefining Kids Content: Mindiful®'s The Moon Show Blends Storytelling and Mindfulness for Every Kid

JotPsych Launches JotMeet, an Integrated Telehealth Product